Members |
targetComponentId |
Haemorrhagic fever with renal syndrome |
Hemorrhagic fever with renal syndrome (disorder) |
Hairworms |
Phylum Nematomorpha (organism) |
infantil pseudokolera |
Acute diarrhea (disorder) |
Half base syndrome |
Cranial nerve disorder |
hallucinogen, icke läkemedel |
Hallucinogenic agent (substance) |
haloperidol 100 mg, injektionsvätska, lösning, ampull |
Haloperidol only product in parenteral dose form |
Haloperidol 100mg/mL injection |
Haloperidol only product in parenteral dose form |
haloperidol 5 mg, injektionsvätska, lösning, ampull |
Haloperidol only product in parenteral dose form |
Haloperidol 5mg/mL injection |
Haloperidol only product in parenteral dose form |
haloperidoldekanoat 50 mg/ml, injektionsvätska, lösning, ampull |
Haloperidol only product in parenteral dose form |
Haloperidol decanoate 50mg/mL solution |
Haloperidol only product in parenteral dose form |
Hansenula anomala |
Wickerhamomyces anomalus (organism) |
Hantavirus serogroup Bhanja |
Bhanja virus |
glad miljö |
Happy environment |
har nämnarvärde som visar koncentrationsstyrka |
Has concentration strength denominator value (attribute) |
har täljarvärde för koncentrationsstyrka |
Has concentration strength numerator value (attribute) |
benägenhet för näsblödning |
Bleeding from nose |
Has nosebleeds - epistaxis |
Bleeding from nose |
har förpackningsstorlek |
Has pack size (attribute) |
har nämnarvärde som visar styrka |
Has presentation strength denominator value (attribute) |
har täljarvärde som visar styrka |
Has presentation strength numerator value (attribute) |
ytegenskaper |
Has surface texture |
Has time |
With time |
frakturtyper enligt Hawkins |
Fracture configurations |
frakturtyp 1 enligt Hawkins |
Hawkins type I fracture |
frakturtyp 2 enligt Hawkins |
Hawkins type II fracture (morphologic abnormality) |
frakturtyp 3 enligt Hawkins |
Hawkins type III fracture |
frakturtyp 4 enligt Hawkins |
Hawkins type IV fracture (morphologic abnormality) |
Hearing analyzer |
Instrument |
Hearing detector |
Instrument |
Hearing transducer |
Instrument |
Heart and heart-lung transplant |
Thorax transplantation |
egenvårdsplan vid hjärtsvikt |
Heart failure self management plan |
laceration av hjärta med sårskada in till brösthålan, utan penetration av hjärtrum |
Laceration of heart |
Heat labile bacterial toxin |
Heat labile bacterial toxin |
pyrexi orsakad av värme |
Heat stroke |
Heat stable bacterial toxin |
Heat stable bacterial toxin |
Heavy metal poisoning |
Product containing heavy metal antagonist (product) |
Heel DXA scan |
Dual energy X-ray absorptiometry of heel (procedure) |
Heel DXA scan |
Dual energy X-ray absorptiometry of heel (procedure) |
Heel DXA scan T score |
Dual energy X-ray photon absorptiometry heel scan T score |
Heel DXA scan T score |
Dual energy X-ray photon absorptiometry heel scan T score |
Heel DXA scan Z score |
Dual energy X-ray photon absorptiometry heel scan Z score (observable entity) |
Heel DXA scan Z score |
Dual energy X-ray photon absorptiometry heel scan Z score (observable entity) |
Heel dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of heel (procedure) |
T-poäng vid DXA-skanning av häl |
Dual energy X-ray photon absorptiometry heel scan T score |
Z-poäng vid DXA-skanning av häl |
Dual energy X-ray photon absorptiometry heel scan Z score (observable entity) |
Helicobacter |
Helicobacter |
Helicobacter nemestrinae |
Helicobacter pylori |
Helicobacter pylori |
Helicobacter pylori |
Helicobacter-like organism |
Helicobacter-like organism |
Helminthosporium rostratum |
Exserohilum rostratum |
hemangiom |
Benign hemangioma |
Hemangiopericytic meningioma |
Solitary fibrous tumor |
hemangiopericytom |
Solitary fibrous tumor |
benignt hemangiopericytom |
Solitary fibrous tumor and hemangiopericytoma grade 1 (morphologic abnormality) |
hemangiopericytom, malignt |
Solitary fibrous tumor and hemangiopericytoma grade 3 (morphologic abnormality) |
Hemarthrosis of other site, NEC |
Hemarthrosis |
Hematoside |
GM3-ganglioside |
Hemoglobin F-Calluna |
Hemoglobin F-Heather |
Hemoglobin F-Iwata |
Hemoglobin F-Minoo |
Hemoglobin F-Kuala Lumpur |
Hemoglobin F-Urumqi |
Hemoglobin F-Siena |
Hemoglobin F-Carlton |
Hemoglobin F-Yamaguchi |
Hemoglobin F-Marietta |
hemoglobin J-Kaohslung (Hb 59(E3), Lys-thr) |
Haemoglobin J-Kaohsiung |
hemoglobin J-Nayanza (Hb 21(B2), Ala-asp) |
Haemoglobin J-Nyanza |
Hemoglobin S |
Hemoglobin S |
Hemoglobin S disease |
Sickle cell-hemoglobin SS disease |
Hemoglobin S disease with crisis |
Hemoglobin SS disease with crisis (disorder) |
Hemoglobin S disease without crisis |
Hemoglobin SS disease without crisis (disorder) |
Hemolysis |
Hemolysis |
Hemolytic disease due to other isoimmunization, NEC |
Hemolytic disease of the newborn due to non-ABO, non-Rh isoimmunization |
Hemolytic uremic syndrome |
Hemolytic uremic syndrome |
Hemorrhagic fever with renal syndrome |
Hemorrhagic fever with renal syndrome (disorder) |
hemorragisk nefrosonefrit |
Hemorrhagic fever with renal syndrome (disorder) |
Hemorrhoidectomy by injection |
Destruction of hemorrhoids by sclerotherapy |
Hepadnavirus |
Family Hepadnaviridae (organism) |
Heparin cofactor I |
Antithrombin III |
heparinnatrium 100 enheter/ml, lösning |
Heparin (as porcine heparin sodium) 100 unit/mL solution for injection |
heparinnatrium 1 000 IE + natriumklorid 0,9 %, infusionsvätska, lösning, ampull |
Product containing only heparin in parenteral dose form (medicinal product form) |
heparinnatrium 10 IE/ml, injektionsvätska, lösning, ampull |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
heparinnatrium 10 IE/ml, lösning |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
Heparin sodium in 0.9% sodium chloride 1000iu/500mL infusion |
Product containing only heparin in parenteral dose form (medicinal product form) |
Hepatectomy |
Excision of liver (procedure) |
Hepatic colic |
Biliary colic |
Hepatitis |
Inflammatory disease of liver |
Hepatitis B group virus |
Genus Orthohepadnavirus (organism) |
humant immunglobulin mot hepatit B 1000 IE, pulver till injektionsvätska, flaska |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
humant immunglobulin mot hepatit B 200 IE, pulver till injektionsvätska, flaska |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
humant immunglobulin mot hepatit B 500 IE, pulver till injektionsvätska, flaska |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis B screening test |
Hepatitis B screening |
screeningtest avseende hepatit B |
Hepatitis B screening |
Hepatitis B screening test |
Hepatitis B screening |
humant immunglobulin mot hepatit B 217 enheter, injektionsvätska, lösning, flaska |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
humant immunglobulin mot hepatit B 312 enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
humant immunglobulin mot hepatit B 312 enheter/ml, injektionsvätska, lösning, flaska 5 ml |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
non-A-non-B-hepatit |
Viral hepatitis |
Hepatitis panel |
Hepatitis panel measurement |
Hepatocerebral encephalopathy |
Hepatic encephalopathy |
Herbaspirillum rubrisualbicans |
Herbaspirillum rubrisubalbicans (organism) |
Hereditary disease |
Hereditary disease |